Abstract Details
|
Michael Johnson, PhD
(Eli Lilly & Company)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Kirk W. Johnson, PhD (Eli Lilly and Company) | No disclosure on file |